| Name | Cinsebrutinib |
|---|
| Description | Cinsebrutinib is a Bruton's tyrosine kinase inhibitor, extracted from patent WO2021207549 (compound 5-6). Cinsebrutinib has the potential for cancer study. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C22H26FN3O2 |
|---|---|
| Molecular Weight | 383.46 |